PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32678313-0	2021	TGFbeta2-mediated epithelial-mesenchymal transition and NF-kappaB pathway activation contribute to osimertinib resistance.	osimertinib	99-110	transforming growth factor beta 2	Homo sapiens	0-8	
32678313-5	2021	The EMT occurrence resulted from osimertinib-induced upregulation of TGFbeta2 that activated SMAD2.	osimertinib	33-44	transforming growth factor beta 2	Homo sapiens	69-77	
32678313-7	2021	In NCI-H1975 cells, osimertinib activated NF-kappaB pathway, evidenced by the increased p65 nuclear translocation, which was abolished by knockdown of TGFbeta2.	osimertinib	20-31	transforming growth factor beta 2	Homo sapiens	151-159	
32678313-10	2021	These findings shed new light on distinct roles of TGFbeta2 in osimertinib-resistant cells and provide new strategies for treatment of this resistant status.	osimertinib	63-74	transforming growth factor beta 2	Homo sapiens	51-59